The drugmaker said the results for giredestrant open the door to adding a treatment option at an early stage of the cancer, ...

Roche's experimental oral drug giredestrant has been shown to cut the risk of recurrence of a common form of breast cancer ...

By embedding standardized questionnaires and algorithms into routine visits, providers can evaluate risk factors such as age, ...

A real-world analysis of more than 60,000 patients in the US finds median survival increased by almost 7 months from 2011 to ...

The rationale is really strong since we're often making decisions for our patients based on single features or ...

A small group of women with advanced breast cancer participated in a trial where they received a vaccine, and all remain ...

"Baywatch" alum Nicole Eggert shared that she thinks about her body and “how she showed up for me” amid breast cancer ...

The study sought to answer questions about how breast cancer risk differs by type of hormonal contraceptive. Doctors say the ...

A single, targeted high dose of radiation delivered before other treatments could completely eradicate tumors in most women with early-stage, operable hormone-positive breast cancer, according to a ...

The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...

A new law is providing better access to breast cancer screenings for Oklahomans. 2 News’ Naomi Keitt listened to experts to ...

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for ...